Multiple myeloma is a plasma cell cancer characterized by the proliferation of monoclonal plasma cells in bone marrow, leading to an overabundance of monoclonal paraprotein (M protein), destruction of bone, and displacement of other hematopoietic cell lines. The condition comprises an estimated 15% of hematologic cancer types. The incidence rate of multiple myeloma has increased by 126% worldwide since 1990. Unlike other cancer types that metastasize to the bone, up to 80% of patients with newly diagnosed multiple myeloma present with osteolytic lesions. Other signs of multiple myeloma include anemia, hypercalcemia, and renal disfunction. Owing to the nature of the disease, most patients with multiple myeloma will experience relapse, with subsequent lines of therapy selected on the basis of prior treatment, patient condition, and patient preference.
How would you approach the diagnosis, monitoring, and management of relapsed/refractory multiple myeloma? Check your knowledge with this quick quiz.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Maria-Victoria Mateos, Winston W. Tan. Fast Five Quiz: Relapsed/Refractory Multiple Myeloma - Medscape - Aug 16, 2023.